Navigation Links
Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
Date:7/24/2009

ANN ARBOR, Mich., July 24 /PRNewswire/ -- Terumo Cardiovascular Systems (Terumo CVS) announced that it has initiated a Phase II Clinical Trial for the Anaconda(TM) AAA (Abdominal Aortic Aneurysm) Stent Graft System in the U.S. The Anaconda system is manufactured by Scotland-based Terumo subsidiary Vascutek Ltd. The first U.S. implant was performed on June 8th at Arizona Heart Hospital by the principal investigator, Julio Rodriguez-Lopez, M.D.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )

The objective of the Vascutek Anaconda Stent Graft System Phase II IDE Study (G030036) is to assess the safety and effectiveness of the Anaconda stent graft system in patients presenting with AAA when compared to historical open surgical repair. The Food and Drug Administration (FDA) has given Terumo CVS approval to enroll 180 patients at 20 sites, some of which will be in Canada. The primary endpoint for the study is the successful treatment of the aneurysm twelve months after the implantation of the device. Patients in the study will be followed for a total of five years.

The Anaconda system is commercially available outside the U.S. where it has been implanted in nearly 4000 patients. It received CE Mark in Europe in April 2005.

According to the Society of Vascular Surgery, physicians diagnose approximately 200,000 people with AAAs in the U.S. annually. Treatment options include medical management of co-morbidities such as hypertension or pulmonary disease, open surgical repair and endovascular repair. Endovascular repair using commercially available devices has been associated with shorter recovery times, reduced hospital stay, and other benefits.


'/>"/>
SOURCE Terumo Cardiovascular Systems
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
2. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
3. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
4. Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
5. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
6. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
7. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
8. Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
9. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
10. Large, Long-Term Study Shows Avandia Has No Increased Overall Cardiovascular Risk Compared to Other Commonly Used Diabetes Medicines
11. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015 /PRNewswire/ - Anything Technologies Media, Inc. (OTC:EXMT) ... Indoor Garden Solutions (FIGS), www.frontiergarden.com has ... the Project Manager for a My Compassion originated ... Group located in Alaska.  The project will be ... finance Teaming Partners. The first phase of the ...
(Date:7/30/2015)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) ... 2015 financial results and provide a corporate update. Arena ... Select Market closes that day. The conference ... callers and 914.495.8552 for international callers. Please specify to ...
(Date:7/30/2015)... -- Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a ... commercialization of prescription ophthalmic pharmaceuticals, today announced that it ... results after the market close on Monday, August 10, ... same day at 4:30 p.m. ET. ... and Rick Eiswirth , Chief Operating Officer and ...
Breaking Medicine Technology:Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2
... NEW YORK, April 12, 2011 Reportlinker.com announces that ... catalogue: Europe Nephrology and Urology Devices ... Europe Nephrology and Urology Devices Market ... GlobalData,s new report, "Europe Nephrology and Urology Devices ...
... NEW YORK, April 12, 2011 Reportlinker.com announces that ... catalogue: Bladder Cancer - Global Drug ... 2011 http://www.reportlinker.com/p0479812/Bladder-Cancer---Global-Drug-Forecasts-and-Treatment-Analysis-to-2020---Volume-1-2011.html ... to 2020 - Volume 1 2011 ...
Cached Medicine Technology:Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 2Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 3Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 4Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 5Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 6Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 7Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 8Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 9Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 10Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 11Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 12Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 13Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 14Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 15Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 2Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 3Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 4Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 5Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 6Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 7Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 8Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 9Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 10Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 11Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 12Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 13Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 14Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 15Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 16Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 17Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 18Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 19Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 20Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 21Reportlinker Adds Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011 22
(Date:7/31/2015)... Waycross, Georgia (PRWEB) , ... July 31, 2015 , ... Easter Seals Southern Georgia’s Heels ... Park near Waycross, Georgia. Start time will be 7:30 AM. The duathlon is a 2 ... quarter mile swim in Laura Walker Lake, a 13 mile bike, and a 3 mile ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... applies when purchasing disability insurance, where price is an important factor to clients ... a leading insurance carrier, offers the Preferred Producer Multi-Life Discount program, where advisers ...
(Date:7/30/2015)... ... , ... When responsible for the care of an aging loved one, summer ... mind: What happens if mom falls? Who will remind Dad to take his medications? ... But not taking time away from caregiving responsibilities can lead to bigger problems – ...
(Date:7/30/2015)... Turks & Caicos Islands, BWI (PRWEB) , ... July 31, 2015 , ... The Venetian ... offer for fall, 2015. Guests who stay at the Venetian will save 40% on ... , The fall months are always quiet in the Turks & Caicos, providing a chance ...
(Date:7/30/2015)... ... 2015 , ... World Patent Marketing, a vertically integrated manufacturer ... can help people during emergencies. , "The worldwide mobile health market revenue will ... World Patent Marketing. "Currently, there are about 97,000 mobile health apps available in ...
Breaking Medicine News(10 mins):Health News:Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia 2Health News:Secura Consultants Gives Advisers Competitive New Edge with Multi-Life Discount Program 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5
... News) -- Men develop type 2 diabetes at a lower ... why men have higher rates of diabetes in many parts ... 51,920 men and 43,137 women in Scotland with diabetes and ... men and 33.69 in women. This difference was most noticeable ...
... (HealthDay News) -- Women with polycystic ovary syndrome (PCOS), an ... to have parents with some form of heart disease, according ... between PCOS and other family medical conditions, we might be ... an earlier stage," the study,s lead author, Michael Davies, an ...
... , FRIDAY, Oct. 7 (HealthDay News) -- Boys with autism ... developing infants seen in their head size, height and weight, ... offer new clues about the underlying mechanisms of autism. A ... larger brain. Boys with brain and body "overgrowth" ...
... that high-calorie energy drink or soda might present more ... double-blind, placebo-controlled study that examined responses to stimulants, an ... or she will respond to other stimulant drugs, possibly ... serious drugs of abuse, such as amphetamine and cocaine. ...
... through organ transplantation has been revolutionized by the development of ... organ. But those antirejection drugs have their own side ... by scientists at Oregon Health & Science University has discovered ... effects. And the discovery means those side effects likely can ...
... , FRIDAY, Oct. 7 (HealthDay News) -- Nearly your ... play games, according to a new study. The finding ... in an attempt to win games, such as rock-paper-scissors, makes ... "Our brain functions to maximize the chance of survival ...
Cached Medicine News:Health News:Boys With Autism May Grow Faster as Babies 2Health News:Boys With Autism May Grow Faster as Babies 3Health News:Jonesing for java: Could caffeine use predict risk for cocaine abuse? 2Health News:Study uncovers why anti-rejection drugs for transplant patients cause hypertension 2
... new SONOLINE G40 ultrasound system brings,the ... an entirely new level of diagnostic ... ultra-portable,system that meets your clinical needs. ... color,Doppler and pulsed-wave Doppler capabilities,the G40 ...
... unique Acid Fast Control Slides ... with appropriate background material. Slides ... positive and negative smear. Can ... No. 353), Ziehl-Neelsen or SDLs ...
PRINCIPLE: The QC-SLIDES™ are specifically designed microscope slides intended to be part of the quality control program to monitor microbiological stains and staining techniques....
Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
Medicine Products: